(NASDAQ:SVRA), NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), of the important November 7, 2025 lead plaintiff deadline. SO WHAT: If you […]
ROSEN, A LONGSTANDING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action- SVRA GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024
King of Prussia, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biotechnology company Alector announced today that the drug, latozinemab, failed to meet the criteria for safety and efficacy in a Phase 3 clinical trial. The study investigated the drug as an intervention for cases of FTD caused by a variant of the gene GRN. Three
Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic Treatment did not slow progression of FTD as measured by the clinical co-primary endpoint GlobeNewswire October 21, 2025 King of Prussia, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biotechnology company Alector announced today that the drug, latozinemab, failed to meet the criteria
(TSX:MTL), OKOTOKS, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group” and/or the “Corporation“) announced today its intention to redeem in full on December 1, 2025 (the “Redemption Date“) all of its outstanding 5.75% convertible unsecured subordinated debentures due November 30, 2026 (“Debentures“) in accordance with the provisions of the
Mullen Group Ltd. Announces the Early Redemption of its 5.75% Convertible Unsecured Subordinated Debentures GlobeNewswire October 21, 2025 OKOTOKS, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group” and/or the “Corporation“) announced today its intention to redeem in full on December 1, 2025 (the “Redemption Date“) all of its outstanding
(CNSX:AIDR),(OTC US:AIRDF),(Other OTC:AIRDF),(Boerse Frankfurt – Freiverkehr:939),(CNSX:AIDR.CN),(Boerse Frankfurt – Freiverkehr:939.F), Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), an independent small-cap research firm, for analyst coverage. FRC is one of the largest independent research
Rocket Doctor AI Engages Fundamental Research Corp. for Analyst Coverage GlobeNewswire October 21, 2025 Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), an independent small-cap research firm, for analyst coverage. FRC is one
NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=173323&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / WHY: New York, N.Y., October 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Corporation (NASDAQ:QMCO) between November 15, 2024 and August 18, 2025, inclusive (the "Class Period"), of the important November 3, 2025 lead